7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephal

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544 22, 544 25, 544 27, 544 28, A61K 31545, C07D50146

Patent

active

042786711

ABSTRACT:
A 7-[2-(2-aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephalosporin derivative of the formula; ##STR1## wherein R.sub.3 is hydrogen or a residue of a nucleophilic compound; R.sub.2 NH is an amino group which may optionally be protected, pharmaceutically acceptable salt or ester thereof, is found to have excellent anti-bacterial activity against a broad spectrum of bacteria inclusive of gram-negative bacteria such as Escherichia coli, Serratia marcescens, Proteus rettgeri, Enterobacter cloacae and Citrobacter freundii. Thus, this compound may be used for an antibacterial agent in therapeutical purposes.

REFERENCES:
patent: 4033950 (1977-07-01), Cook et al.
patent: 4066762 (1978-01-01), Dunn et al.
patent: 4098888 (1978-07-01), Ochiai
patent: 4202893 (1980-05-01), Heymes et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido] cephal will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2164713

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.